Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Colibri Isotopes
Lubbock, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Colibri Isotopes is developing advanced accelerator-based isotope production and mass separation technologies. Its platform is capable of producing a wide variety of crucial therapeutic and diagnostic isotopes, aiming to address global shortages, particularly of lutetium-177 and yttrium-90 for cancer therapy. Recent partnerships target both scaling and application in global supply chains, but clinical validation/data for medical application is not explicitly reported as underway yet.
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- RadiopharmaceuticalRadioisotopeSmall molecule
- Industry
- Chemicals & Materials
02
Partnerships
Laurentis Energy Partners
Beyond the preview
Go deeper on Colibri Isotopes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Colibri Isotopes.